Chiome Bioscience Inc. (TYO:4583)

Chiome Bioscience Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,028	17,565	7,044	8,619	7,860	7,348
Market Cap Growth	25.02%	149.35%	-18.27%	9.67%	6.96%	9.29%
Enterprise Value	8,491	16,627	6,019	7,215	5,987	4,666
Last Close Price	148.00	269.00	135.00	178.00	195.00	186.00
PS Ratio	12.70	22.50	10.32	13.66	11.02	15.28
PB Ratio	5.69	9.15	6.09	4.81	4.15	2.36
P/TBV Ratio	5.69	9.15	6.09	4.81	4.15	2.36
EV/Sales Ratio	10.75	21.29	8.82	11.44	8.40	9.70
Debt / Equity Ratio	0.16	0.15	0.25	0.10	0.10	0.06
Asset Turnover	0.40	0.37	0.34	0.28	0.24	0.15
Inventory Turnover	6.23	6.31	4.19	21.72	3.92	3.02
Quick Ratio	4.83	4.33	2.66	5.05	4.72	8.17
Current Ratio	5.35	4.74	3.02	5.65	5.65	9.48
Return on Equity (ROE)	-65.33%	-66.33%	-82.76%	-67.48%	-59.16%	-45.15%
Return on Assets (ROA)	-30.73%	-30.53%	-37.97%	-34.54%	-28.59%	-25.46%
Return on Capital (ROIC)	-33.76%	-35.30%	-44.00%	-38.84%	-31.08%	-27.14%
Earnings Yield	-9.80%	-5.81%	-17.32%	-14.42%	-18.83%	-17.61%
FCF Yield	-	-5.70%	-15.18%	-13.82%	-14.39%	-18.51%
Buyback Yield / Dilution	-20.60%	-17.48%	-12.64%	-9.20%	-12.26%	-14.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.